Roche Holdings will invest 50 billion US dollars in pharmaceutical and diagnostic businesses in the US over the next five years. In the context of Donald Trump's protectionist agenda, the Swiss pharmaceutical company joined a group of companies to increase investment in the US. Roche said in a press release on Tuesday that related plans include expanding and upgrading manufacturing and distribution capabilities in Kentucky, Indiana, New Jersey, Oregon, and California. Roche also plans to establish a production plant to support the expansion of next-generation diet pills, but did not disclose the location of the factory.

Roche Holdings will invest 50 billion US dollars in pharmaceutical and diagnostic businesses in the US over the next five years. In the context of Donald Trump's protectionist agenda, the Swiss pharmaceutical company joined a group of companies to increase investment in the US. Roche said in a press release on Tuesday that related plans include expanding and upgrading manufacturing and distribution capabilities in Kentucky, Indiana, New Jersey, Oregon, and California. Roche also plans to establish a production plant to support the expansion of next-generation diet pills, but did not disclose the location of the factory.